Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wouter Bos

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
European Journal of Internal Medicine|October 19, 2017
The professional in the lead?Wouter Bos
Nederlands Tijdschrift Voor Geneeskunde|January 8, 2015
[Patients are not prepared to choose: another example of a failing market?]Marcel Levi, Wouter Bos
RMD Open|February 5, 2022
Effectiveness of electronic drug monitoring feedback to increase adherence in patients with RA initiating a biological DMARD: a randomised clinical trialRenske Cf Hebing, Iremnur Aksu, Jos Wr Twisk, et al.
International Journal of Environmental Research and Public Health|October 13, 2021
Adherence to Telemonitoring by Electronic Patient-Reported Outcome Measures in Patients with Chronic Diseases: A Systematic ReviewJim Wiegel, Bart Seppen, Marike van der Leeden, et al.
The Journal of Rheumatology|August 4, 2012
The acute-phase response is not predictive for the development of arthritis in seropositive arthralgia - a prospective cohort studyMaarten Limper, Lotte van de Stadt, Wouter Bos, et al.
RMD Open|March 9, 2021
Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trialLaurette van Boheemen, Samina Turk, Marian van Beers-Tas, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
European Journal of Internal Medicine|October 19, 2017
The professional in the lead?Wouter Bos
Nederlands Tijdschrift Voor Geneeskunde|January 8, 2015
[Patients are not prepared to choose: another example of a failing market?]Marcel Levi, Wouter Bos
RMD Open|February 5, 2022
Effectiveness of electronic drug monitoring feedback to increase adherence in patients with RA initiating a biological DMARD: a randomised clinical trialRenske Cf Hebing, Iremnur Aksu, Jos Wr Twisk, et al.
International Journal of Environmental Research and Public Health|October 13, 2021
Adherence to Telemonitoring by Electronic Patient-Reported Outcome Measures in Patients with Chronic Diseases: A Systematic ReviewJim Wiegel, Bart Seppen, Marike van der Leeden, et al.
The Journal of Rheumatology|August 4, 2012
The acute-phase response is not predictive for the development of arthritis in seropositive arthralgia - a prospective cohort studyMaarten Limper, Lotte van de Stadt, Wouter Bos, et al.
RMD Open|March 9, 2021
Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trialLaurette van Boheemen, Samina Turk, Marian van Beers-Tas, et al.
Pageof 1